Future of NGS-Based cancer tests | ZS

Insights

Will NGS-Based Cancer Tests Become Routine?

Jon Roffman

Jon Roffman, Managing Principal, ZS Associates, discusses whether NGS-based cancer tests will become routine with Debra Patt, MD, MPH, MBA, Vice President, Texas Oncology.



Related Videos


CAR-T Center and Patients

How Can a CAR-T Center Get Established and Effectively Treat Patients



Manufacturers and CAR-T

How Can Manufacturers Help Institutions Prepare for CAR-T Therapies



Future of CAR-T therapies

Will Tomorrow's CAR-T Therapy Innovations Solve Today's Challenges


Next-Gen Sequencing

Next-Gen Sequencing is Transforming Oncology Practices



Hazards of Misinformation




Oncology Clinical Trials


What Lies Ahead




Future of Cancer Care